Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neoplastic Cells, Circulating | 23 | 2025 | 949 | 1.960 |
Why?
|
Gene Expression Regulation, Neoplastic | 20 | 2021 | 8628 | 0.460 |
Why?
|
Breast Neoplasms | 23 | 2023 | 21178 | 0.420 |
Why?
|
Neoplasm Metastasis | 8 | 2020 | 4892 | 0.270 |
Why?
|
Immediate-Early Proteins | 2 | 2021 | 444 | 0.260 |
Why?
|
Oligonucleotide Array Sequence Analysis | 8 | 2014 | 3797 | 0.250 |
Why?
|
Proto-Oncogene Proteins c-fos | 3 | 2021 | 582 | 0.240 |
Why?
|
Receptors, Androgen | 3 | 2018 | 1089 | 0.240 |
Why?
|
Leukapheresis | 1 | 2025 | 150 | 0.230 |
Why?
|
Nuclear Receptor Subfamily 4, Group A, Member 1 | 2 | 2021 | 67 | 0.230 |
Why?
|
Drug Resistance, Neoplasm | 7 | 2018 | 5332 | 0.200 |
Why?
|
Cell Line, Tumor | 21 | 2022 | 17097 | 0.190 |
Why?
|
Prostatic Neoplasms | 8 | 2025 | 11097 | 0.190 |
Why?
|
Sterol Regulatory Element Binding Protein 2 | 1 | 2020 | 58 | 0.180 |
Why?
|
Epithelial-Mesenchymal Transition | 3 | 2015 | 754 | 0.170 |
Why?
|
Wnt Proteins | 2 | 2015 | 723 | 0.170 |
Why?
|
Gene Expression Profiling | 11 | 2017 | 9532 | 0.170 |
Why?
|
Transferrin | 1 | 2020 | 283 | 0.170 |
Why?
|
Postmenopause | 1 | 2008 | 2518 | 0.160 |
Why?
|
Lipogenesis | 1 | 2020 | 217 | 0.160 |
Why?
|
Sequence Analysis, RNA | 8 | 2020 | 2040 | 0.140 |
Why?
|
Ribosomal Proteins | 1 | 2020 | 369 | 0.140 |
Why?
|
Prolactin | 1 | 2019 | 627 | 0.140 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2020 | 627 | 0.140 |
Why?
|
Microfluidic Analytical Techniques | 3 | 2025 | 789 | 0.140 |
Why?
|
Transforming Growth Factor beta | 2 | 2023 | 1995 | 0.140 |
Why?
|
beta-Globins | 1 | 2017 | 111 | 0.130 |
Why?
|
Mitosis | 1 | 2021 | 1176 | 0.130 |
Why?
|
DNA, Satellite | 1 | 2015 | 67 | 0.130 |
Why?
|
Tumor Suppressor Proteins | 2 | 2015 | 2800 | 0.120 |
Why?
|
Gene Regulatory Networks | 2 | 2017 | 1752 | 0.120 |
Why?
|
Mitogen-Activated Protein Kinase 7 | 1 | 2015 | 66 | 0.120 |
Why?
|
Centromere | 1 | 2015 | 214 | 0.120 |
Why?
|
Xenograft Model Antitumor Assays | 6 | 2021 | 3608 | 0.120 |
Why?
|
Chromatin Assembly and Disassembly | 2 | 2021 | 632 | 0.120 |
Why?
|
Mice | 22 | 2023 | 81912 | 0.110 |
Why?
|
Phenylthiohydantoin | 1 | 2015 | 206 | 0.110 |
Why?
|
RNA | 3 | 2018 | 2715 | 0.110 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 2015 | 781 | 0.110 |
Why?
|
Stromal Cells | 1 | 2019 | 1335 | 0.110 |
Why?
|
Receptor, Adenosine A2B | 1 | 2013 | 34 | 0.110 |
Why?
|
Signal Transduction | 10 | 2021 | 23621 | 0.100 |
Why?
|
Gene Knockdown Techniques | 4 | 2020 | 1604 | 0.100 |
Why?
|
Animals | 27 | 2023 | 168965 | 0.100 |
Why?
|
Cell Proliferation | 4 | 2021 | 10455 | 0.100 |
Why?
|
Receptor, erbB-2 | 3 | 2017 | 2599 | 0.090 |
Why?
|
RNA Interference | 4 | 2017 | 2829 | 0.090 |
Why?
|
Combinatorial Chemistry Techniques | 1 | 2011 | 136 | 0.090 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2015 | 699 | 0.090 |
Why?
|
Single-Cell Analysis | 5 | 2025 | 2538 | 0.090 |
Why?
|
Melanoma | 2 | 2020 | 5702 | 0.090 |
Why?
|
Tumor Cells, Cultured | 4 | 2021 | 6106 | 0.090 |
Why?
|
Neoplasm Transplantation | 4 | 2020 | 2012 | 0.090 |
Why?
|
Peptide Library | 1 | 2011 | 351 | 0.080 |
Why?
|
Neoplasms, Hormone-Dependent | 1 | 2012 | 409 | 0.080 |
Why?
|
Oncogene Protein p21(ras) | 1 | 2009 | 69 | 0.080 |
Why?
|
Estrogen Receptor Modulators | 1 | 2009 | 58 | 0.080 |
Why?
|
Cell Cycle | 2 | 2015 | 2927 | 0.080 |
Why?
|
Organic Cation Transport Proteins | 1 | 2009 | 61 | 0.080 |
Why?
|
Proteomics | 2 | 2022 | 3913 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-myc | 2 | 2017 | 998 | 0.080 |
Why?
|
Neoplasms | 7 | 2025 | 22350 | 0.080 |
Why?
|
Zinc Fingers | 1 | 2011 | 577 | 0.080 |
Why?
|
DNA Methylation | 1 | 2023 | 4426 | 0.080 |
Why?
|
Mice, Inbred NOD | 3 | 2021 | 1837 | 0.080 |
Why?
|
Histone Deacetylase Inhibitors | 3 | 2013 | 777 | 0.080 |
Why?
|
Embryonic Stem Cells | 1 | 2015 | 1244 | 0.070 |
Why?
|
Reactive Oxygen Species | 2 | 2017 | 2144 | 0.070 |
Why?
|
RNA, Small Interfering | 4 | 2020 | 3427 | 0.070 |
Why?
|
Transcription Factors | 3 | 2013 | 12158 | 0.070 |
Why?
|
Mice, Nude | 4 | 2017 | 3618 | 0.070 |
Why?
|
Estrogen Receptor alpha | 3 | 2021 | 581 | 0.070 |
Why?
|
Chromatin | 3 | 2015 | 2980 | 0.070 |
Why?
|
BRCA1 Protein | 1 | 2014 | 1155 | 0.070 |
Why?
|
Genes, ras | 1 | 2009 | 656 | 0.070 |
Why?
|
Humans | 44 | 2025 | 767040 | 0.070 |
Why?
|
Extracellular Matrix | 1 | 2014 | 1733 | 0.070 |
Why?
|
Androgen Antagonists | 1 | 2015 | 1412 | 0.070 |
Why?
|
Molecular Targeted Therapy | 2 | 2017 | 2824 | 0.070 |
Why?
|
Repressor Proteins | 2 | 2015 | 2979 | 0.070 |
Why?
|
Brain Neoplasms | 2 | 2020 | 9108 | 0.070 |
Why?
|
Protein Processing, Post-Translational | 1 | 2013 | 1965 | 0.060 |
Why?
|
Pancreatic Neoplasms | 2 | 2014 | 5446 | 0.060 |
Why?
|
Bone Neoplasms | 1 | 2018 | 2563 | 0.060 |
Why?
|
Cell Survival | 5 | 2017 | 5750 | 0.060 |
Why?
|
Microfluidics | 2 | 2025 | 650 | 0.060 |
Why?
|
Female | 26 | 2025 | 396660 | 0.060 |
Why?
|
beta Catenin | 1 | 2010 | 1048 | 0.060 |
Why?
|
Fibroblasts | 2 | 2019 | 4167 | 0.060 |
Why?
|
Cell Division | 1 | 2011 | 4473 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 2 | 2018 | 6513 | 0.050 |
Why?
|
Mice, SCID | 2 | 2021 | 2626 | 0.050 |
Why?
|
Estrogen Antagonists | 1 | 2023 | 151 | 0.050 |
Why?
|
Disease Models, Animal | 5 | 2023 | 18330 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2011 | 2457 | 0.050 |
Why?
|
Valproic Acid | 1 | 2005 | 444 | 0.050 |
Why?
|
Up-Regulation | 3 | 2019 | 4143 | 0.050 |
Why?
|
Abnormalities, Drug-Induced | 1 | 2005 | 337 | 0.050 |
Why?
|
Hydroxamic Acids | 1 | 2005 | 483 | 0.050 |
Why?
|
Phenylacetates | 1 | 2021 | 112 | 0.050 |
Why?
|
Meta-Analysis as Topic | 1 | 2006 | 1364 | 0.050 |
Why?
|
Cell Line | 5 | 2015 | 15567 | 0.050 |
Why?
|
Aneuploidy | 1 | 2025 | 573 | 0.050 |
Why?
|
Nuclear Proteins | 1 | 2015 | 5794 | 0.040 |
Why?
|
Enzyme Inhibitors | 2 | 2014 | 3726 | 0.040 |
Why?
|
Homeodomain Proteins | 1 | 2009 | 2429 | 0.040 |
Why?
|
Cell Movement | 4 | 2014 | 5203 | 0.040 |
Why?
|
Lung Neoplasms | 2 | 2023 | 13491 | 0.040 |
Why?
|
MicroRNAs | 1 | 2015 | 3792 | 0.040 |
Why?
|
3' Untranslated Regions | 1 | 2021 | 515 | 0.040 |
Why?
|
Tumor Microenvironment | 2 | 2023 | 3944 | 0.040 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2022 | 2883 | 0.040 |
Why?
|
Mammary Glands, Animal | 1 | 2020 | 273 | 0.040 |
Why?
|
Retinoid X Receptors | 1 | 2019 | 91 | 0.040 |
Why?
|
Spheroids, Cellular | 1 | 2020 | 328 | 0.040 |
Why?
|
Cell Separation | 2 | 2014 | 1717 | 0.040 |
Why?
|
Indoles | 2 | 2021 | 1836 | 0.040 |
Why?
|
Skin Neoplasms | 1 | 2018 | 5859 | 0.040 |
Why?
|
Cell Hypoxia | 1 | 2020 | 661 | 0.040 |
Why?
|
Stereotaxic Techniques | 1 | 2020 | 551 | 0.040 |
Why?
|
Mesoderm | 2 | 2013 | 679 | 0.040 |
Why?
|
Antineoplastic Agents, Hormonal | 2 | 2018 | 1536 | 0.040 |
Why?
|
Tamoxifen | 2 | 2014 | 966 | 0.040 |
Why?
|
Genomic Instability | 1 | 2021 | 716 | 0.040 |
Why?
|
Anoikis | 1 | 2017 | 49 | 0.030 |
Why?
|
RNA Polymerase II | 1 | 2021 | 549 | 0.030 |
Why?
|
Carboxy-Lyases | 1 | 2017 | 85 | 0.030 |
Why?
|
Peptide Synthases | 1 | 2017 | 81 | 0.030 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2019 | 319 | 0.030 |
Why?
|
E2F1 Transcription Factor | 1 | 2017 | 182 | 0.030 |
Why?
|
Cyclooxygenase 2 | 1 | 2019 | 597 | 0.030 |
Why?
|
Cytoprotection | 1 | 2017 | 199 | 0.030 |
Why?
|
Antineoplastic Agents | 2 | 2021 | 13650 | 0.030 |
Why?
|
Abdominal Neoplasms | 1 | 2018 | 286 | 0.030 |
Why?
|
Mice, Inbred BALB C | 2 | 2017 | 6226 | 0.030 |
Why?
|
Dinoprostone | 1 | 2019 | 597 | 0.030 |
Why?
|
Epigenesis, Genetic | 2 | 2023 | 3828 | 0.030 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2017 | 2952 | 0.030 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2019 | 2843 | 0.030 |
Why?
|
Anticonvulsants | 1 | 2005 | 1921 | 0.030 |
Why?
|
Receptors, Estrogen | 1 | 2023 | 2252 | 0.030 |
Why?
|
Osteonectin | 1 | 2014 | 33 | 0.030 |
Why?
|
gamma Catenin | 1 | 2014 | 45 | 0.030 |
Why?
|
Male | 11 | 2025 | 364203 | 0.030 |
Why?
|
Retinal Dehydrogenase | 1 | 2014 | 78 | 0.030 |
Why?
|
Computational Biology | 1 | 2006 | 3567 | 0.030 |
Why?
|
Epidermal Growth Factor | 1 | 2017 | 697 | 0.030 |
Why?
|
Nucleic Acid Hybridization | 1 | 2015 | 1305 | 0.030 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2017 | 506 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2020 | 1791 | 0.030 |
Why?
|
Brain | 1 | 2020 | 27163 | 0.030 |
Why?
|
Receptor, Notch1 | 1 | 2016 | 518 | 0.030 |
Why?
|
Promoter Regions, Genetic | 2 | 2015 | 5796 | 0.030 |
Why?
|
Adenosine A2 Receptor Antagonists | 1 | 2013 | 50 | 0.030 |
Why?
|
Estradiol | 2 | 2011 | 1951 | 0.030 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2022 | 2061 | 0.030 |
Why?
|
Blotting, Western | 2 | 2011 | 5022 | 0.030 |
Why?
|
Binding Sites | 1 | 2021 | 6014 | 0.030 |
Why?
|
Wnt2 Protein | 1 | 2012 | 29 | 0.030 |
Why?
|
Contact Inhibition | 1 | 2012 | 46 | 0.030 |
Why?
|
Alternative Splicing | 1 | 2018 | 1103 | 0.030 |
Why?
|
Pseudopodia | 1 | 2013 | 167 | 0.030 |
Why?
|
Adipogenesis | 1 | 2015 | 370 | 0.030 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2025 | 3667 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2021 | 4280 | 0.020 |
Why?
|
Wilms Tumor | 1 | 2015 | 378 | 0.020 |
Why?
|
DNA Damage | 2 | 2014 | 2469 | 0.020 |
Why?
|
Disease Progression | 1 | 2009 | 13646 | 0.020 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2014 | 428 | 0.020 |
Why?
|
Phenotype | 2 | 2023 | 16718 | 0.020 |
Why?
|
Cell Growth Processes | 1 | 2012 | 380 | 0.020 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2014 | 719 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2008 | 15424 | 0.020 |
Why?
|
Transcription, Genetic | 3 | 2013 | 7611 | 0.020 |
Why?
|
Sequence Analysis, DNA | 2 | 2014 | 4780 | 0.020 |
Why?
|
Phthalazines | 1 | 2014 | 397 | 0.020 |
Why?
|
Epithelial Cells | 2 | 2013 | 3698 | 0.020 |
Why?
|
Metabolomics | 1 | 2020 | 1675 | 0.020 |
Why?
|
Dacarbazine | 1 | 2014 | 552 | 0.020 |
Why?
|
Acetylation | 1 | 2013 | 1055 | 0.020 |
Why?
|
Methylation | 1 | 2013 | 1076 | 0.020 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2012 | 252 | 0.020 |
Why?
|
Poly T | 1 | 2010 | 6 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2015 | 11063 | 0.020 |
Why?
|
RNA Splicing | 1 | 2015 | 903 | 0.020 |
Why?
|
Melanoma, Experimental | 1 | 2014 | 557 | 0.020 |
Why?
|
Reverse Transcription | 1 | 2010 | 48 | 0.020 |
Why?
|
Genes, Neoplasm | 1 | 2012 | 369 | 0.020 |
Why?
|
Phloroglucinol | 1 | 2010 | 6 | 0.020 |
Why?
|
Culture | 1 | 2014 | 622 | 0.020 |
Why?
|
HCT116 Cells | 1 | 2011 | 403 | 0.020 |
Why?
|
Neoplasms, Experimental | 1 | 2015 | 1228 | 0.020 |
Why?
|
Mutation | 3 | 2021 | 30211 | 0.020 |
Why?
|
Nitriles | 1 | 2015 | 980 | 0.020 |
Why?
|
RNA, Neoplasm | 1 | 2013 | 748 | 0.020 |
Why?
|
Cadherins | 1 | 2015 | 903 | 0.020 |
Why?
|
Estrogens | 1 | 2017 | 1536 | 0.020 |
Why?
|
Genome-Wide Association Study | 1 | 2009 | 12790 | 0.020 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2014 | 904 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-rel | 1 | 2009 | 71 | 0.020 |
Why?
|
Benzamides | 1 | 2015 | 1376 | 0.020 |
Why?
|
DNA | 1 | 2023 | 7210 | 0.020 |
Why?
|
Stress, Physiological | 1 | 2017 | 1407 | 0.020 |
Why?
|
Histone Deacetylases | 1 | 2013 | 712 | 0.020 |
Why?
|
Genes, Lethal | 1 | 2009 | 224 | 0.020 |
Why?
|
Jumonji Domain-Containing Histone Demethylases | 1 | 2010 | 168 | 0.020 |
Why?
|
Transforming Growth Factor beta2 | 1 | 2009 | 71 | 0.020 |
Why?
|
Transcriptional Activation | 1 | 2015 | 1751 | 0.020 |
Why?
|
Prognosis | 3 | 2017 | 29963 | 0.020 |
Why?
|
Antioxidants | 1 | 2017 | 1671 | 0.020 |
Why?
|
Cell Count | 1 | 2013 | 1825 | 0.020 |
Why?
|
Heterocyclic Compounds, 3-Ring | 1 | 2011 | 296 | 0.020 |
Why?
|
Luminescent Proteins | 1 | 2011 | 839 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2011 | 10748 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2023 | 11872 | 0.020 |
Why?
|
NIH 3T3 Cells | 1 | 2010 | 655 | 0.020 |
Why?
|
PTEN Phosphohydrolase | 1 | 2014 | 1119 | 0.020 |
Why?
|
Mammary Glands, Human | 1 | 2009 | 201 | 0.020 |
Why?
|
bcl-X Protein | 1 | 2009 | 412 | 0.020 |
Why?
|
Receptor, IGF Type 1 | 1 | 2010 | 384 | 0.020 |
Why?
|
Apoptosis | 2 | 2017 | 9513 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2010 | 751 | 0.020 |
Why?
|
Prostate | 1 | 2015 | 1761 | 0.020 |
Why?
|
Gene Frequency | 1 | 2014 | 3621 | 0.020 |
Why?
|
Histone Demethylases | 1 | 2010 | 328 | 0.020 |
Why?
|
Molecular Structure | 1 | 2011 | 1882 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2014 | 1646 | 0.020 |
Why?
|
Immunoblotting | 1 | 2010 | 1647 | 0.020 |
Why?
|
Genotype | 1 | 2021 | 13035 | 0.020 |
Why?
|
RNA, Messenger | 2 | 2012 | 12793 | 0.020 |
Why?
|
Clone Cells | 1 | 2009 | 1669 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2022 | 5693 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2009 | 1337 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2014 | 4114 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2011 | 1969 | 0.020 |
Why?
|
Metabolism | 1 | 2006 | 193 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2020 | 18989 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2013 | 3611 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2013 | 2391 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2011 | 2721 | 0.010 |
Why?
|
Plasmids | 1 | 2009 | 2268 | 0.010 |
Why?
|
Antigens, CD | 1 | 2015 | 4032 | 0.010 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2014 | 2058 | 0.010 |
Why?
|
Plant Proteins | 1 | 2006 | 376 | 0.010 |
Why?
|
Models, Biological | 2 | 2011 | 9464 | 0.010 |
Why?
|
False Positive Reactions | 1 | 2006 | 959 | 0.010 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2009 | 1150 | 0.010 |
Why?
|
Oncogenes | 1 | 2009 | 1232 | 0.010 |
Why?
|
Mitochondrial Proteins | 1 | 2009 | 980 | 0.010 |
Why?
|
Gene Expression Regulation | 2 | 2015 | 11923 | 0.010 |
Why?
|
Piperazines | 1 | 2014 | 2548 | 0.010 |
Why?
|
Xenopus | 1 | 2005 | 710 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2006 | 1989 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2015 | 4522 | 0.010 |
Why?
|
Spinal Dysraphism | 1 | 2005 | 179 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2021 | 9410 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2014 | 4925 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2009 | 4616 | 0.010 |
Why?
|
Species Specificity | 1 | 2005 | 2412 | 0.010 |
Why?
|
Middle Aged | 2 | 2018 | 223233 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2009 | 5891 | 0.010 |
Why?
|
Alleles | 1 | 2009 | 6893 | 0.010 |
Why?
|
Kidney Neoplasms | 1 | 2015 | 4282 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2009 | 3561 | 0.010 |
Why?
|
Rats | 1 | 2013 | 23713 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2006 | 2698 | 0.010 |
Why?
|
Prospective Studies | 1 | 2021 | 54886 | 0.010 |
Why?
|
Stem Cells | 1 | 2009 | 3535 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 2015 | 6966 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2014 | 22361 | 0.010 |
Why?
|
Aged | 1 | 2008 | 171319 | 0.010 |
Why?
|
Internet | 1 | 2006 | 3114 | 0.010 |
Why?
|
Zebrafish | 1 | 2005 | 3036 | 0.010 |
Why?
|
Adult | 1 | 2008 | 223317 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2009 | 7868 | 0.010 |
Why?
|
Software | 1 | 2006 | 4472 | 0.010 |
Why?
|
Models, Statistical | 1 | 2006 | 5098 | 0.010 |
Why?
|
Time Factors | 1 | 2011 | 40154 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2006 | 20169 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2011 | 65295 | 0.000 |
Why?
|